ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0658

ACCORD: A Novel Rheumatology Transition Clinic Structure for Adolescent and Young Adult Patients with Childhood Onset Rheumatic Disease

Rebecca Overbury1, Kelly Huynh2, Tracy Frech1, John Bohnsack1 and Aimee Hersh1, 1University of Utah, Salt Lake City, UT, 2Intermountain Health Care, Salt Lake City, UT

Meeting: ACR Convergence 2021

Keywords: Clinical practice guidelines, Juvenile idiopathic arthritis, Outcome measures, Pediatric rheumatology, registry

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Measures & Measurement of Healthcare Quality Poster (0623–0659)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: The transition of health care from Pediatric to Adult providers for adolescents and young adults with childhood onset rheumatic disease continues to be associated with poor outcomes. In 2018, we initiated a novel transition clinic structure (ACCORD), integrating an Internal Medicine – Pediatrics trained Adult Rheumatologist in a Pediatric Rheumatology clinic to guide this transition. Our goal is to improve transition outcomes in childhood onset rheumatic disease. We report the preliminary outcomes of this intervention.

Methods: In the ACCORD clinic, the Adult Rheumatologist assumed medical management and guided the patient and their family through a transition curriculum. If they consented to do so, patients and their families were enrolled in a prospective observational outcomes research registry. Initial data from this transition clinic is reported. Descriptive statistics are employed.

Results: From November 2018 – December 2020, the ACCORD transition clinic Adult Rheumatologist saw 177 patients and enrolled 57 patients in the registry. From this registry, all patients reviewed the Transition Policy with the Adult Rheumatologist; 45 (78.9%) completed at least one Transition Readiness Assessment; 12 (21.1%) twice completed the Transition Readiness Assessment. 22 (38.6%) transitioned to an Adult Rheumatologist; 17 (29.8%) continued care post-transition with the ACCORD Adult Rheumatologist outside of the transition clinic. The median time between a last ACCORD clinic visit and a first Adult Rheumatology visit was 5.1 months (SD = 5.0, range 1.6 – 8.7). No transitioned patients enrolled in the Registry have failed to schedule with and be seen by an Adult Rheumatologist. There was no statistical significant difference in no-show rates between the ACCORD clinic and the general Pediatric Rheumatology clinic; both for patients of all ages, or for those limited to ≥ 16 years of age.

Conclusion: Our experience demonstrates the feasibility of our clinic model. Our registry shows transition rates of 100.0% and a median transition interval of 5.1 months. This is an improvement over transition rates reported elsewhere that did not implement our model. No-show rates in the ACCORD clinic are not different from our general Pediatric Rheumatology clinic. We believe this structure could be applied to other primary care and subspecialty clinics.

Table 1. ACCORD patients enrolled in the prospective observational registry (n = 57)

Table 2. Diagnoses of ACCORD patients enrolled in the prospective observational registry (n = 57)

Table 3. Clinic no-show rates


Disclosures: R. Overbury, None; K. Huynh, None; T. Frech, None; J. Bohnsack, Pfizer, 12, Site Investigator, Funded Research, Janssen, 12, Site Investigator, Funded Research, Bristol Myers Squibb, 12, Site Investigator, Funded Research, Abbvie, 12, Site Investigator, Funded Research, Roche, 12, Site Investigator, Funded Research, Baxter, 12, Site Investigator, Funded Research, General Electric, 11; A. Hersh, None.

To cite this abstract in AMA style:

Overbury R, Huynh K, Frech T, Bohnsack J, Hersh A. ACCORD: A Novel Rheumatology Transition Clinic Structure for Adolescent and Young Adult Patients with Childhood Onset Rheumatic Disease [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/accord-a-novel-rheumatology-transition-clinic-structure-for-adolescent-and-young-adult-patients-with-childhood-onset-rheumatic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/accord-a-novel-rheumatology-transition-clinic-structure-for-adolescent-and-young-adult-patients-with-childhood-onset-rheumatic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology